Dr Lal PathLabs Limited approves acquisition of property in New Delhi

The Board of Directors of Dr. Lal PathLabs Limited, have on September 23, 2025, approved the proposal for acquisition of immovable property situated in New Delhi. The acquisition of said immovable property comprising four (4) units i.e., 101, 102 at first floor and 201 & 202 at second floor, a Shop situated at ground floor alongwith right to use of space in basement and designated parking area, situated at Plot No. Site-II, District Centre, Shalimar Palace, Shalimar Bagh, New Delhi - 110088 shall be subject to necessary requisite approvals, consents, permissions from the concerned authorities.

The Agreement(s) shall be entered by and between the Company, The South Indian Bank Limited, (the Mortgagee/ Lender) and other the Mortgagors/ Borrowers viz. Alternative Learning Systems Limited, Mr. Manoj Kumar Singh, Mr. Jojo Thayil Mathew, Mrs. Renju Jojo Mathews, Mr. Shashank Atom, Mrs. Preeti Sharma, and the Builder viz. Aggarwal Towers Private Limited.

The Consolidated consideration amount shall be upto INR 74.51 Crores (exclusive of Stamp Duty, Registration Fees, Brokerage/ Commission and other incidental expenses on actual basis)

Shares of Dr. Lal Path Labs Ltd. was last trading in BSE at Rs. 3329.45 as compared to the previous close of Rs. 3392.45. The total number of shares traded during the day was 11754 in over 967 trades.

The stock hit an intraday high of Rs. 3399.00 and intraday low of 3305.00. The net turnover during the day was Rs. 39054578.00.

Source : Equity Bulls

Keywords

DrLalPathLabs INE600L01024 HealthcareServices Acquisition ImmovableProperty NewDelhi